AP3491A - Triazolopyridines - Google Patents

Triazolopyridines

Info

Publication number
AP3491A
AP3491A AP2013007182A AP2013007182A AP3491A AP 3491 A AP3491 A AP 3491A AP 2013007182 A AP2013007182 A AP 2013007182A AP 2013007182 A AP2013007182 A AP 2013007182A AP 3491 A AP3491 A AP 3491A
Authority
AP
ARIPO
Prior art keywords
triazolopyridines
Prior art date
Application number
AP2013007182A
Other languages
English (en)
Other versions
AP2013007182A0 (en
Inventor
Hans Briem
Philip Lienau
Antje Margret Wengner
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AP2013007182A0 publication Critical patent/AP2013007182A0/xx
Application granted granted Critical
Publication of AP3491A publication Critical patent/AP3491A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2013007182A 2011-04-21 2012-04-16 Triazolopyridines AP3491A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11163342 2011-04-21
EP11167872 2011-05-27
PCT/EP2012/056914 WO2012143329A1 (en) 2011-04-21 2012-04-16 Triazolopyridines

Publications (2)

Publication Number Publication Date
AP2013007182A0 AP2013007182A0 (en) 2013-10-31
AP3491A true AP3491A (en) 2015-12-31

Family

ID=46124297

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007182A AP3491A (en) 2011-04-21 2012-04-16 Triazolopyridines

Country Status (39)

Country Link
US (1) US20140120087A1 (xx)
EP (1) EP2699575B1 (xx)
JP (1) JP5989091B2 (xx)
KR (1) KR20140025470A (xx)
CN (1) CN103608350B (xx)
AP (1) AP3491A (xx)
AR (1) AR086191A1 (xx)
AU (1) AU2012244859B2 (xx)
CA (1) CA2833657A1 (xx)
CL (1) CL2013003044A1 (xx)
CO (1) CO6801751A2 (xx)
CR (1) CR20130539A (xx)
CY (1) CY1116439T1 (xx)
DK (1) DK2699575T3 (xx)
DO (1) DOP2013000244A (xx)
EA (1) EA023766B1 (xx)
EC (1) ECSP13013011A (xx)
ES (1) ES2539265T3 (xx)
GT (1) GT201300254A (xx)
HK (1) HK1190398A1 (xx)
HR (1) HRP20150517T1 (xx)
HU (1) HUE025496T2 (xx)
IL (1) IL228704A0 (xx)
JO (1) JO3040B1 (xx)
MA (1) MA35049B1 (xx)
ME (1) ME02143B (xx)
MX (1) MX348783B (xx)
MY (1) MY164939A (xx)
PE (1) PE20141351A1 (xx)
PL (1) PL2699575T3 (xx)
PT (1) PT2699575E (xx)
RS (1) RS54044B1 (xx)
SA (1) SA112330466B1 (xx)
SG (1) SG194003A1 (xx)
SI (1) SI2699575T1 (xx)
TW (1) TWI558703B (xx)
UY (1) UY34034A (xx)
WO (1) WO2012143329A1 (xx)
ZA (1) ZA201308707B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2699558T (pt) 2011-04-21 2016-12-29 Gilead Sciences Inc Compostos de benzotiazole e a sua utilização farmacêutica
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
ES2605946T3 (es) 2012-03-14 2017-03-17 Bayer Intellectual Property Gmbh Imidazopiridazinas sustituidas
AU2013289381A1 (en) * 2012-07-10 2015-01-22 Bayer Pharma Aktiengesellschaft Method for preparing substituted triazolopyridines
WO2014020043A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014020041A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
US9670202B2 (en) * 2013-06-07 2017-06-06 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines
US20160264568A1 (en) * 2013-06-07 2016-09-15 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
WO2014198594A1 (en) * 2013-06-10 2014-12-18 Bayer Pharma Aktiengesellschaft Novel compounds for the treatment of cancer
PT3008062T (pt) 2013-06-11 2017-06-07 Bayer Pharma AG Derivados de profármaco de triazolopiridinas substituídas
MA38656A1 (fr) * 2013-06-11 2018-05-31 Bayer Pharma AG Combinaisons pour le traitement du cancer comprenant un inhibiteur de la kinase mps-1 et un inhibiteur de la mitose
EP2860177A3 (en) 2013-09-20 2015-06-10 Bayer Intellectual Property GmbH Synthesis of functionalized arenes
EP3283642B1 (en) 2015-04-17 2023-10-11 Netherlands Translational Research Center Holding B.V. Prognostic biomarkers for ttk inhibitor chemotherapy
WO2018166493A1 (zh) * 2017-03-16 2018-09-20 江苏恒瑞医药股份有限公司 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
AU2020257301A1 (en) 2019-04-18 2021-11-11 The Johns Hopkins University Substituted 2-amino-pyrazolyl-(1,2,4)triazolo(1,5a) pyridine derivatives and use thereof
US11529350B2 (en) 2019-07-03 2022-12-20 Sumitomo Pharma Oncology, Inc. Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008025821A1 (en) * 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
WO2011063908A1 (en) * 2009-11-30 2011-06-03 Bayer Schering Pharma Aktiengesellschaft Triazolopyridines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
RU2007109778A (ru) 2004-08-17 2008-09-27 Галдерма Ресерч Энд Девелопмент, С.Н.С. (Fr) Новые биароматические соединения, которые активируют рецепторы типа ppar, и их применение в косметических и фармацевтических композициях
KR20100049073A (ko) 2007-07-18 2010-05-11 노파르티스 아게 비시클릭 헤테로아릴 화합물 및 키나제 억제제로서의 그의 용도
BRPI0815709A2 (pt) 2007-08-23 2017-06-13 Astrazeneca Ab composro, composição farmacêutica, e, uso de um composto.
JP2010536917A (ja) * 2007-08-31 2010-12-02 メルク セローノ ソシエテ アノニム トリアゾロピリジン化合物と、ask阻害剤としてのその化合物の利用法
GB0719803D0 (en) * 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
BRPI0819606A2 (pt) * 2007-11-27 2017-05-09 Cellzome Ltd amino triazóis como inobidores de pi3k
SG173610A1 (en) 2009-02-13 2011-09-29 Fovea Pharmaceuticals Sa [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
CN102413831B (zh) 2009-04-29 2014-06-04 拜耳知识产权有限责任公司 取代的咪唑并喹喔啉
CA2772790C (en) 2009-09-04 2017-06-27 Benjamin Bader Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008025821A1 (en) * 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
WO2011063908A1 (en) * 2009-11-30 2011-06-03 Bayer Schering Pharma Aktiengesellschaft Triazolopyridines

Also Published As

Publication number Publication date
MA35049B1 (fr) 2014-04-03
US20140120087A1 (en) 2014-05-01
SG194003A1 (en) 2013-11-29
PT2699575E (pt) 2015-07-29
MX348783B (es) 2017-06-28
NZ616456A (en) 2015-09-25
KR20140025470A (ko) 2014-03-04
JP5989091B2 (ja) 2016-09-07
HK1190398A1 (zh) 2014-07-04
AU2012244859A1 (en) 2013-10-31
SI2699575T1 (sl) 2015-10-30
CN103608350A (zh) 2014-02-26
IL228704A0 (en) 2013-12-31
ZA201308707B (en) 2016-07-27
AR086191A1 (es) 2013-11-27
EP2699575B1 (en) 2015-03-25
CN103608350B (zh) 2015-11-25
JO3040B1 (ar) 2016-09-05
RS54044B1 (en) 2015-10-30
EA201301181A1 (ru) 2014-08-29
HUE025496T2 (en) 2016-04-28
JP2014511887A (ja) 2014-05-19
SA112330466B1 (ar) 2015-09-28
MY164939A (en) 2018-02-15
TW201245194A (en) 2012-11-16
CA2833657A1 (en) 2012-10-26
TWI558703B (zh) 2016-11-21
CY1116439T1 (el) 2017-02-08
AU2012244859B2 (en) 2017-06-08
UY34034A (es) 2012-11-30
CO6801751A2 (es) 2013-11-29
EP2699575A1 (en) 2014-02-26
ME02143B (me) 2015-10-20
WO2012143329A1 (en) 2012-10-26
EA023766B1 (ru) 2016-07-29
PL2699575T3 (pl) 2015-08-31
GT201300254A (es) 2015-09-01
PE20141351A1 (es) 2014-11-01
DK2699575T3 (da) 2015-06-22
DOP2013000244A (es) 2014-03-16
ECSP13013011A (es) 2013-12-31
CL2013003044A1 (es) 2014-05-02
HRP20150517T1 (hr) 2015-06-19
MX2013012289A (es) 2013-11-21
ES2539265T3 (es) 2015-06-29
CR20130539A (es) 2013-12-04
AP2013007182A0 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
DK3505720T3 (en) Cementering under styret tryk
DK3424953T3 (en) Terapeutiske antistoffer
AP3491A (en) Triazolopyridines
EP2790561A4 (en) DISHWASHER
EP2755962A4 (en) AZAINDAZOLES
EP2715659A4 (en) ABOUT FEED
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
EP2723631A4 (en) QUADFOILER
EP2776444A4 (en) dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
EP2695208A4 (en) MICRO-THERMOCOUPLE
EP2708561A4 (en) BIO-PIN
DK2770906T3 (en) Applanationstonometer
EP2684382A4 (en) EARPHONES
IL227377A0 (en) Combinations
EP2698098A4 (en) campimeter
EP2702929A4 (en) campimeter
GB201109024D0 (en) Can
GB201100001D0 (en) TidySqueeze2
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5171P (en) Sunparamiho Mandevilla xamabilis
AU5031P (en) BESYS Beschorneria yuccoides
AU5026P (en) Goldstrike Agapanthus inapertus
AP00723S1 (en) Autorickshaw
AU340282S (en) Can